 |
| Assisting Lifestyle Changes as a Treatment for Hypertension (Graphic: Business Wire) |
Assisting Lifestyle Changes as a Treatment for Hypertension
TOKYO, Nov 3 (Bernama-BUSINESS WIRE) -- CureApp, Inc. (Head Office: Chuo-ku, Tokyo; CEO: Kohta Satake) announces the start of insurance coverage for its CureApp HT Hypertension Adjunctive Treatment App (hereafter, CureApp HT), a DTx*¹ solution treating hypertension, in Japan from September 1, 2022. Looking ahead, the app will be prescribed and provided to patients with hypertension as a health insurance treatment at medical institutions.
TOKYO, Nov 3 (Bernama-BUSINESS WIRE) -- CureApp, Inc. (Head Office: Chuo-ku, Tokyo; CEO: Kohta Satake) announces the start of insurance coverage for its CureApp HT Hypertension Adjunctive Treatment App (hereafter, CureApp HT), a DTx*¹ solution treating hypertension, in Japan from September 1, 2022. Looking ahead, the app will be prescribed and provided to patients with hypertension as a health insurance treatment at medical institutions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221031005330/en/
After confirming the efficacy and safety of CureApp HT through clinical trials, the results of a Japanese Phase III domestic multicenter randomized controlled trial were published in EHJ, one of the most well-respected peer reviewed journals in the world in 2021. In April 2022, CureApp HT was the first digital therapeutics app for hypertension to receive government approval in the world, and the app has been covered by insurance since September 1. This marks the first case of a DTx treatment solution being covered by insurance in the field of hypertension in the world. Looking ahead, CureApp looks to pursue further commercialization efforts of this Japanese-led medical innovation. The impact of hypertension is seen beyond Japan’s borders, and efforts to correct patient lifestyle habits is a common theme across the globe. Therefore, CureApp also plans to proactively expand CureApp HT’s reach all over the world, beginning with the U.S.
Importance of lifestyle changes, current challenges, and the potential of CureAppHT
The Guidelines for the Management of Hypertension 2019 describes that “lifestyle changes are important because not only are they expected to produce a hypotensive effect, but also they prevent hypertension”. The guidelines also say that “lifestyle guidance should be provided to all patients with hypertension, because they could increase the hypotensive effect and reduce the dosage of antihypertensive drugs”. Despite this recommendation, there has been little uptake in such behavioral therapy due to the challenges presented in having patients implement lifestyle changes on a continual basis and limited time of doctor consultation sessions. It is also said that a certain period of guided intervention*² is needed for lifestyle changes to take hold. CureApp HT helps to connect doctors and patients, and promotes lifestyle changes that were previously difficult to maintain while ensuring to sustain modified behavior in patients.
No comments:
Post a Comment